RB1 and glioblastoma: Sunitinib has been shown to induce G1-phase arrest in acute myeloid leukemia (AML) cells [45], similar to our observations here with RB, but this contrasts with the G2/M-phase arrest seen in sunitinib-treated glioblastoma cultures [44].